1e
19
1
49
2
2
18
1b
1d
18
39
45
1d
2 29
1d
25
Charles P. O'Brien, MD, PhD
88
45
Emeritus Professor of Psychiatry
7
61
Department: Psychiatry
4
1
b
1d
46
Contact information
49
4
3
3
3
2
29
4
b
1f
49
University of Pennsylvania
21 Treatment Research Center
3c 3900 Chestnut Street
Philadelphia, PA 19104-6178
26
21 Treatment Research Center
3c 3900 Chestnut Street
Philadelphia, PA 19104-6178
36
Office: 215-222-3200 ext.132
32 Fax: 215-386-6770
24
81
32 Fax: 215-386-6770
24
Email:
obrien@upenn.edu
12
obrien@upenn.edu
13
Education:
21 9 B.S. c
2a Tulane University, 1960.
21 9 M.D. c
2e Tulane Medical School, 1964.
21 9 M.S. 1d ( Neurophysiology) c
f Physiology 2d The Graduate School, Tulane University 16 , 1964.
21 a Ph.D. 1c (Neurophysiology) c
10 Physiology 2f The Graduate School, Tulane University 16 , 1966.
c
3
3
3
3
8a
Permanent link21 9 B.S. c
2a Tulane University, 1960.
21 9 M.D. c
2e Tulane Medical School, 1964.
21 9 M.S. 1d ( Neurophysiology) c
f Physiology 2d The Graduate School, Tulane University 16 , 1964.
21 a Ph.D. 1c (Neurophysiology) c
10 Physiology 2f The Graduate School, Tulane University 16 , 1966.
c
2 29
21
1e
1d
24
2b
29
27
23
1d7 Anton, R.F., Litten, R.Z., Falk, D.E., Palumbo, J.M., Bartus, R.T., Robinson, R.L., Kranzler, H.R., Kosten, T.R., Meyer, R.E., O’Brien, C.P., Mann, K., Meulien, D. : The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Drug Alcohol Depend 37(2): 402-411, 2012 Notes: PMCID: PC3242301.
ec Cheatle, M.D. and O’Brien, C.P. : Opioid therapy in patients with chronic non-cancer pain: Diagnostic and clinical challenges. Adv Psychoso Med 30: 61-91, 2011.
162 O’Brien, C.P., Gastfriend, D.R., Forman, R.F., Schweizer, E., and Pettinati, H.M. : Long-Term Opioid Blockade and Hedonic Response: Preliminary Data from Two Open-Label Extension Studies with Extended-Release Naltrexone. The American Journal on Addictions 20(2): 106-112, 2011.
9b O'Brien, C.P.: Addiction and Dependence in DSM-V. Addiction 106(5): 866-867, 2011.
a6 O'Brien, C.P.: Neuroplasticity in addictive disorders. Dialogues Clin Neurosci 11: 350, 2009.
d2 O’Brien, C.P., McLellan, A.T., Childress, A.R. and Woody, G.E: Penn/VA Center for Studies of Addiction. Neuropharmacology 56: 44, 2009.
82 O'Brien, C.P.: The CAGE Questionnaire for Detection of Alcoholism: A Remarkably 19 Useful but Simple Tool 32 JAMA 300(17): 2054, 2008.
ab O'Brien, C.P.: Clinical Crossroad: a 50-year-old woman addicted to heroin. JAMA 300(3): 314, 2008.
c2 O'Brien, C.P.: Evidence-based treatments of addiction. Philosophical Transactions of the Royal Society B 363: 3277, 2008.
2c
7
1d
1f
Selected Publications
127 Langleben, D.D., Busch, E.L., O’Brien, C.P., Elman, I. : Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence. Psychopharmacology 220(3): 559-64, 2012 Notes: . PMCID: PMC3302938.1d7 Anton, R.F., Litten, R.Z., Falk, D.E., Palumbo, J.M., Bartus, R.T., Robinson, R.L., Kranzler, H.R., Kosten, T.R., Meyer, R.E., O’Brien, C.P., Mann, K., Meulien, D. : The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Drug Alcohol Depend 37(2): 402-411, 2012 Notes: PMCID: PC3242301.
ec Cheatle, M.D. and O’Brien, C.P. : Opioid therapy in patients with chronic non-cancer pain: Diagnostic and clinical challenges. Adv Psychoso Med 30: 61-91, 2011.
162 O’Brien, C.P., Gastfriend, D.R., Forman, R.F., Schweizer, E., and Pettinati, H.M. : Long-Term Opioid Blockade and Hedonic Response: Preliminary Data from Two Open-Label Extension Studies with Extended-Release Naltrexone. The American Journal on Addictions 20(2): 106-112, 2011.
9b O'Brien, C.P.: Addiction and Dependence in DSM-V. Addiction 106(5): 866-867, 2011.
a6 O'Brien, C.P.: Neuroplasticity in addictive disorders. Dialogues Clin Neurosci 11: 350, 2009.
d2 O’Brien, C.P., McLellan, A.T., Childress, A.R. and Woody, G.E: Penn/VA Center for Studies of Addiction. Neuropharmacology 56: 44, 2009.
82 O'Brien, C.P.: The CAGE Questionnaire for Detection of Alcoholism: A Remarkably 19 Useful but Simple Tool 32 JAMA 300(17): 2054, 2008.
ab O'Brien, C.P.: Clinical Crossroad: a 50-year-old woman addicted to heroin. JAMA 300(3): 314, 2008.
c2 O'Brien, C.P.: Evidence-based treatments of addiction. Philosophical Transactions of the Royal Society B 363: 3277, 2008.
2c